Additionally, some infections may exacerbate or trigger psoriasis, such as strep throat. Regardless of whether you are on a biologic or immunosuppressive medication for psoriasis, it’s essential ...

Many people with psoriasis can safely get tattoos, but the process may cause flare-ups due to what's known as the Koebner phenomenon. This happens when the skin injury from the tattoo triggers new ...

Moderate to severe psoriasis describes how much of your body is covered in red, scaly psoriasis patches. Moderate psoriasis covers 3% to 10% of your body. Severe psoriasis covers more than 10% of ...

Psoriasis is a chronic autoimmune disease in which the body's immune system attacks skin cells with inflammation, causing them to multiply faster than they can be shed. This causes the cells to pile ...

Psoriasis is a disease that causes itchy, dry patches on your skin. Up to 40% of people with psoriasis have symptoms before they're 16 years old, and 10% get it before they're 10. Children can ...

The candidate fell short in a phase 2 psoriasis trial, prompting the French drugmaker to pull back from plans to develop the molecule as a monotherapy. Led by AbbVie’s Humira, biologic TNF ...

A new study found that 57.6% of patients with psoriasis achieved super responder status with guselkumab, characterised by complete skin clearance at week 20. Bio-naive status and lower comorbidity ...

A RECENT clinical trial has compared the effectiveness of IL-17 and IL-23 biologics in treating moderate to severe plaque psoriasis, particularly in patients with coexisting metabolic syndrome (MetS).

Otezla, a first-in-class treatment for plaque psoriasis has been approved in the US. Celgene's drug Otezla (apremilast) is an oral, selective inhibitor of phosphodiesterase 4 (PDE4) and gained its ...

The following is a summary of “Treatment of plaque psoriasis with guselkumab reduces systemic inflammatory burden as measured by neutrophil/lymphocyte ratio, platelet/lymphocyte ratio and ...

Patanjali Ayurved's research, published in the Journal of Inflammation Research, reveals promising results for their Ayurvedic treatment of psoriasis using Psorogrit tablets and Divya Taila.

Icotrokinra appears to be an effective treatment for adolescent patients with moderate to severe plaque psoriasis, according to a subgroup analysis of the ICONIC-LEAD study. The randomized, ...